Alpha Cognition ROA 2020-2024 | ACOG
Current and historical return on assets (ROA) values for Alpha Cognition (ACOG) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Alpha Cognition ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2024-06-30 |
$-0.02B |
$0.00B |
-711.11% |
| 2024-03-31 |
$-0.02B |
$0.00B |
-755.56% |
| 2023-12-31 |
$-0.01B |
$0.00B |
-509.09% |
| 2023-09-30 |
$-0.01B |
$0.00B |
-400.00% |
| 2023-06-30 |
$-0.01B |
$0.00B |
-314.29% |
| 2023-03-31 |
$-0.01B |
$0.01B |
-231.58% |
| 2022-12-31 |
$-0.01B |
$0.00B |
-192.00% |
| 2022-09-30 |
$-0.01B |
$0.00B |
-125.71% |
| 2022-06-30 |
$-0.01B |
$0.01B |
-140.54% |
| 2022-03-31 |
$-0.01B |
$0.01B |
-111.11% |
| 2021-12-31 |
$-0.02B |
$0.01B |
-230.30% |
| 2021-09-30 |
$-0.02B |
$0.01B |
-257.14% |
| 2021-06-30 |
$-0.02B |
$0.01B |
-272.73% |
| 2021-03-31 |
$-0.02B |
$0.01B |
-425.00% |
| 2020-12-31 |
$-0.01B |
$0.01B |
-300.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.035B |
$0.000B |
|
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
|
